Clinical trial
Safety, Feasibility, and Biomarker Effects of Time-restricted Eating for 12 Weeks in Early-stage Huntington's Disease.
NCT06490367 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Feasibility, and Biomarker Effects of Time-restricted Eating for 12 Weeks in Early-stage Huntington's Disease.
- Lead sponsor
- Oregon Health and Science University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 29, 2024
- Completion date
- May 30, 2025
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.